Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Collins, BJ; Blum, MG; Parker, RE; Chang, AC; Blair, KSA; Zorn, GL; Christman, BW; Pierson, RN
   Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection
   JOURNAL OF APPLIED PHYSIOLOGY
   
   B.J. Collins et al., "Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection", J APP PHYSL, 90(6), 2001, pp. 2257-2268
2. Platt, JL
   The humoral barrier to transplantation of the liver: Is it more real than apparent?
   LIVER TRANSPLANTATION
   
   J.L. Platt, "The humoral barrier to transplantation of the liver: Is it more real than apparent?", LIVER TRANS, 7(2), 2001, pp. 90-92
3. Platt, JL
   Xenotransplantation of the liver: Is more complement control needed?
   LIVER TRANSPLANTATION
   
   J.L. Platt, "Xenotransplantation of the liver: Is more complement control needed?", LIVER TRANS, 7(10), 2001, pp. 933-934
4. Janss, AJ; Maity, A; Tang, CB; Muschel, RJ; McKenna, WG; Sutton, L; Phillips, PC
   Decreased cyclin B1 expression contributes to G(2) delay in human brain tumor cells after treatment with camptothecin
   NEURO-ONCOLOGY
   
   A.J. Janss et al., "Decreased cyclin B1 expression contributes to G(2) delay in human brain tumor cells after treatment with camptothecin", NEURO-ONCOL, 3(1), 2001, pp. 11-21
5. Bhujwalla, ZM; Artemov, D; Natarajan, K; Ackerstaff, E; Solaiyappan, M
   Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts
   NEOPLASIA
   
   Z.M. Bhujwalla et al., "Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts", NEOPLASIA, 3(2), 2001, pp. 143-153
6. Akhter, J; Lu, Y; Finlay, I; Pourgholami, MH; Morris, DL
   1 alpha,25-Dihydroxyvitamin D-3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2
   ANZ journal of surgery
   
   J. Akhter et al., "1 alpha,25-Dihydroxyvitamin D-3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2", AUST NZ J S, 71(7), 2001, pp. 414-417
7. Frenkel, GD; Caffrey, PB
   A prevention strategy for circumventing drug resistance in cancer chemotherapy
   CURRENT PHARMACEUTICAL DESIGN
   
   G.D. Frenkel e P.B. Caffrey, "A prevention strategy for circumventing drug resistance in cancer chemotherapy", CUR PHARM D, 7(16), 2001, pp. 1595-1614
8. Jung, LL; Zamboni, WC
   Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
   DRUG RESISTANCE UPDATES
   
   L.L. Jung e W.C. Zamboni, "Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?", DRUG RESIST, 4(3), 2001, pp. 152-167
9. Collignon, P; Purdy, L
   Xenografts: are the risks so great that we should not proceed?
   MICROBES AND INFECTION
   
   P. Collignon e L. Purdy, "Xenografts: are the risks so great that we should not proceed?", MICROBES IN, 3(4), 2001, pp. 341-348
10. Kobinger, GP; Weiner, DJ; Yu, QC; Wilson, JM
    Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo
    NATURE BIOTECHNOLOGY
    
    G.P. Kobinger et al., "Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo", NAT BIOTECH, 19(3), 2001, pp. 225-230
11. Wu, AM
    Tools for pretargeted radioimmunotherapy
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    
    A.M. Wu, "Tools for pretargeted radioimmunotherapy", CANC BIO R, 16(2), 2001, pp. 103-108
12. Milenic, DE; Roselli, M; Mirzadeh, S; Pippin, CG; Gansow, OA; Colcher, D; Brechbiel, MW; Schlom, J
    In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    
    D.E. Milenic et al., "In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates", CANC BIO R, 16(2), 2001, pp. 133-146
13. Williams, LE; Beatty, BG; Shively, JE; Beatty, JD
    Accumulation of radiolabeled anti-CEA antibody (mT84.66) in the case of multiple LS174T tumors in a nude mouse model
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    
    L.E. Williams et al., "Accumulation of radiolabeled anti-CEA antibody (mT84.66) in the case of multiple LS174T tumors in a nude mouse model", CANC BIO R, 16(2), 2001, pp. 147-157
14. Bergman, I; Barmada, MA; Griffin, JA; Slamon, DJ
    Treatment of meningeal breast cancer xenografts in the rat using an anti-P185/HER2 antibody
    CLINICAL CANCER RESEARCH
    
    I. Bergman et al., "Treatment of meningeal breast cancer xenografts in the rat using an anti-P185/HER2 antibody", CLIN CANC R, 7(7), 2001, pp. 2050-2056
15. van Acker, FAA; Boven, E; Kramer, K; Haenen, GRMM; Bast, A; van der Vijgh, WJF
    Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity
    CLINICAL CANCER RESEARCH
    
    F.A.A. van Acker et al., "Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity", CLIN CANC R, 7(5), 2001, pp. 1378-1384
16. Tahtis, K; Lee, FT; Smyth, FE; Power, BE; Renner, C; Brechbiel, MW; Old, LJ; Hudson, PJ; Scott, AM
    Biodistribution properties of (111)Indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab ')(2) constructs in a breast carcinoma xenograft model
    CLINICAL CANCER RESEARCH
    
    K. Tahtis et al., "Biodistribution properties of (111)Indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab ')(2) constructs in a breast carcinoma xenograft model", CLIN CANC R, 7(4), 2001, pp. 1061-1072
17. Fujimoto-Ouchi, K; Tanaka, Y; Tominaga, T
    Schedule dependency of antitumor activity in combination therapy with capecitabine/5 '-deoxy-5-fluorouridine and docetaxel in breast cancer models
    CLINICAL CANCER RESEARCH
    
    K. Fujimoto-Ouchi et al., "Schedule dependency of antitumor activity in combination therapy with capecitabine/5 '-deoxy-5-fluorouridine and docetaxel in breast cancer models", CLIN CANC R, 7(4), 2001, pp. 1079-1086
18. Komatsu, T; Yamazaki, H; Shimada, N; Nagayama, S; Kawaguchi, Y; Nakajima, M; Yokoi, T
    Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver
    CLINICAL CANCER RESEARCH
    
    T. Komatsu et al., "Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver", CLIN CANC R, 7(3), 2001, pp. 675-681
19. Takimoto, CH
    Why drugs fail: Of mice and men revisited
    CLINICAL CANCER RESEARCH
    
    C.H. Takimoto, "Why drugs fail: Of mice and men revisited", CLIN CANC R, 7(2), 2001, pp. 229-230
20. Kirstein, MN; Houghton, PJ; Cheshire, PJ; Richmond, LB; Smith, AK; Hanna, SK; Stewart, CF
    Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts
    CLINICAL CANCER RESEARCH
    
    M.N. Kirstein et al., "Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts", CLIN CANC R, 7(2), 2001, pp. 358-366
21. Kelland, LR; Smith, V; Valenti, M; Patterson, L; Clarke, PA; Detre, S; End, D; Howes, AJ; Dowsett, M; Workman, P; Johnston, SRD
    Preclinical antitumor activity and pharmacodynamic studies with the farnesylprotein transferase inhibitor R115777 in human breast cancer
    CLINICAL CANCER RESEARCH
    
    L.R. Kelland et al., "Preclinical antitumor activity and pharmacodynamic studies with the farnesylprotein transferase inhibitor R115777 in human breast cancer", CLIN CANC R, 7(11), 2001, pp. 3544-3550
22. Cardillo, TM; Ying, ZL; Gold, DV
    Therapeutic advantage of (90)Yttrium-versus (131)Iodine-labeled PAM4 antibody in experimental pancreatic cancer
    CLINICAL CANCER RESEARCH
    
    T.M. Cardillo et al., "Therapeutic advantage of (90)Yttrium-versus (131)Iodine-labeled PAM4 antibody in experimental pancreatic cancer", CLIN CANC R, 7(10), 2001, pp. 3186-3192
23. Khokhar, NZ; She, Y; Rusch, VW; Sirotnak, FM
    Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: Further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums
    CLINICAL CANCER RESEARCH
    
    N.Z. Khokhar et al., "Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: Further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums", CLIN CANC R, 7(10), 2001, pp. 3199-3205
24. Guichard, S; Montazeri, A; Chatelut, E; Hennebelle, I; Bugat, R; Canal, P
    Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: Pharmacokinetic and pharmacodynamic evaluation
    CLINICAL CANCER RESEARCH
    
    S. Guichard et al., "Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: Pharmacokinetic and pharmacodynamic evaluation", CLIN CANC R, 7(10), 2001, pp. 3222-3228
25. Takahashi, N; Li, WW; Banerjee, D; Scotto, KW; Bertino, JR
    Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells
    CLINICAL CANCER RESEARCH
    
    N. Takahashi et al., "Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells", CLIN CANC R, 7(10), 2001, pp. 3251-3257
26. Koshkina, NV; Waldrep, JC; Roberts, LE; Golunski, E; Melton, S; Knight, V
    Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model
    CLINICAL CANCER RESEARCH
    
    N.V. Koshkina et al., "Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model", CLIN CANC R, 7(10), 2001, pp. 3258-3262
27. Blaney, S; Berg, SL; Pratt, C; Weitman, S; Sullivan, J; Luchtman-Jones, L; Bernstein, M
    A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study
    CLINICAL CANCER RESEARCH
    
    S. Blaney et al., "A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study", CLIN CANC R, 7(1), 2001, pp. 32-37
28. Goel, A; Augustine, S; Baranowska-Kortylewicz, J; Colcher, D; Booth, BJM; Pavlinkova, G; Tempero, M; Batra, SK
    Single-dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using I-131-labeled multivalent CC49 single-chain Fvs(1)
    CLINICAL CANCER RESEARCH
    
    A. Goel et al., "Single-dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using I-131-labeled multivalent CC49 single-chain Fvs(1)", CLIN CANC R, 7(1), 2001, pp. 175-184
29. Cascalho, M; Platt, JL
    The immunological barrier to xenotransplantation
    IMMUNITY
    
    M. Cascalho e J.L. Platt, "The immunological barrier to xenotransplantation", IMMUNITY, 14(4), 2001, pp. 437-446
30. Stromberg, I; Tornqvist, N; Johansson, S; Bygdeman, M; Almqvist, PM
    Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons
    MICROSCOPY RESEARCH AND TECHNIQUE
    
    I. Stromberg et al., "Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons", MICROSC RES, 54(5), 2001, pp. 287-297
31. Beranek, JT
    Quick disposal of dead cardiomyocytes: An ultimate proof of their apoptosis
    JOURNAL OF HEART AND LUNG TRANSPLANTATION
    
    J.T. Beranek, "Quick disposal of dead cardiomyocytes: An ultimate proof of their apoptosis", J HEART LUN, 20(8), 2001, pp. 923-924
32. Rose, AG; Cooper, DKC
    Cardiac hyperacute, rejection: A new look or a skewed look at an old problem?
    JOURNAL OF HEART AND LUNG TRANSPLANTATION
    
    A.G. Rose e D.K.C. Cooper, "Cardiac hyperacute, rejection: A new look or a skewed look at an old problem?", J HEART LUN, 20(1), 2001, pp. 103-105
33. Bals, R; Weiner, DJ; Meegalla, RL; Accurso, F; Wilson, JM
    Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    
    R. Bals et al., "Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid", AM J RESP C, 25(1), 2001, pp. 21-25
34. Wang, XR; Zhang, YL; Amberson, A; Engelhardt, JF
    New models of the tracheal airway define the glandular contribution to airway surface fluid and electrolyte composition
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    
    X.R. Wang et al., "New models of the tracheal airway define the glandular contribution to airway surface fluid and electrolyte composition", AM J RESP C, 24(2), 2001, pp. 195-202
35. Kawashiri, S; Kojima, K; Kumagai, S; Nakagawa, K; Yamamoto, E
    Effects of chemotherapy on invasion and metastasis of oral cavity cancer in mice
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    
    S. Kawashiri et al., "Effects of chemotherapy on invasion and metastasis of oral cavity cancer in mice", HEAD NECK, 23(9), 2001, pp. 764-771
36. Gali, H; Hoffman, TJ; Sieckman, GL; Owen, NK; Katti, KV; Volkert, WA
    Synthesis, characterization, and labeling with Tc-99m/Re-188 of peptide conjugates containing a dithia-bisphosphine chelating agent
    BIOCONJUGATE CHEMISTRY
    
    H. Gali et al., "Synthesis, characterization, and labeling with Tc-99m/Re-188 of peptide conjugates containing a dithia-bisphosphine chelating agent", BIOCONJ CHE, 12(3), 2001, pp. 354-363
37. Vaidyanathan, G; Affleck, DJ; Li, J; Welsh, P; Zalutsky, MR
    A polar substituent containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[I-131]iodobenzbate ([I-131]SGMIB)
    BIOCONJUGATE CHEMISTRY
    
    G. Vaidyanathan et al., "A polar substituent containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[I-131]iodobenzbate ([I-131]SGMIB)", BIOCONJ CHE, 12(3), 2001, pp. 428-438
38. Yazaki, PJ; Wu, AM; Tsai, SW; Williams, LE; Ikle, DN; Wong, JYC; Shively, JE; Raubitschek, AA
    Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and T84.66 minibody: Comparison to radioiodinated fragments
    BIOCONJUGATE CHEMISTRY
    
    P.J. Yazaki et al., "Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and T84.66 minibody: Comparison to radioiodinated fragments", BIOCONJ CHE, 12(2), 2001, pp. 220-228
39. Kruczynski, A; Hill, BT
    Vinflunine, the latest Vinca alkaloid in clinical development - A review of its preclinical anticancer properties
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    A. Kruczynski e B.T. Hill, "Vinflunine, the latest Vinca alkaloid in clinical development - A review of its preclinical anticancer properties", CR R ONC H, 40(2), 2001, pp. 159-173
40. DeNardo, GL; Juweid, ME; White, CA; Wiseman, GA; DeNardo, SJ
    Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    G.L. DeNardo et al., "Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing", CR R ONC H, 39(1-2), 2001, pp. 203-218
41. Giavazzi, R; Taraboletti, G
    Preclinical development of metalloproteasis inhibitors in cancer therapy
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    R. Giavazzi e G. Taraboletti, "Preclinical development of metalloproteasis inhibitors in cancer therapy", CR R ONC H, 37(1), 2001, pp. 53-60
42. Zahm, JM; Baconnais, S; Davidson, DJ; Webb, S; Dorin, J; Bonnet, N; Balossier, G; Puchelle, E
    X-ray microanalysis of airway surface liquid collected in cystic fibrosis mice
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    
    J.M. Zahm et al., "X-ray microanalysis of airway surface liquid collected in cystic fibrosis mice", AM J P-LUNG, 281(2), 2001, pp. L309-L313
43. Yamamoto, K; Noda, K; Hatae, M; Kudo, T; Hasegawa, K; Nishimura, R; Honjo, H; Yajima, A; Sato, S; Mizutani, K; Yakushiji, M; Terashima, Y; Ochiai, K; Sasaki, H; Ozaki, M
    Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer
    ONCOLOGY REPORTS
    
    K. Yamamoto et al., "Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer", ONCOL REP, 8(2), 2001, pp. 273-277
44. Sun, CL; Yamato, T; Furukawa, T; Ohnishi, Y; Kijima, H; Horii, A
    Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines
    ONCOLOGY REPORTS
    
    C.L. Sun et al., "Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines", ONCOL REP, 8(1), 2001, pp. 89-92
45. Naruke, M; Abe, Y; Hatanaka, H; Ohnishi, Y; Yamazaki, H; Kijima, H; Nakamura, M; Ueyama, Y; Kobayashi, K
    Interleukin-10 expression is correlated with growth fraction in human non-small cell lung cancer xenografts
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    M. Naruke et al., "Interleukin-10 expression is correlated with growth fraction in human non-small cell lung cancer xenografts", INT J ONCOL, 18(6), 2001, pp. 1213-1217
46. Agrawal, S; Kandimalla, ER; Yu, D; Hollister, BA; Chen, SF; Dexter, DL; Alford, TL; Hill, B; Bailey, KS; Bono, CP; Knoerzer, DL; Morton, PA
    Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    S. Agrawal et al., "Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides", INT J ONCOL, 18(5), 2001, pp. 1061-1069
47. Foulon, CF; Welsh, PC; Bigner, DD; Zalutsky, MR
    Positively charged templates for labeling internalizing antibodies: comparison of N-succinimidyl 5-Iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR
    NUCLEAR MEDICINE AND BIOLOGY
    
    C.F. Foulon et al., "Positively charged templates for labeling internalizing antibodies: comparison of N-succinimidyl 5-Iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR", NUCL MED BI, 28(7), 2001, pp. 769-777
48. Bonasera, TA; Ortu, G; Rozen, Y; Krais, R; Freedman, NMT; Chisin, R; Gazit, A; Levitzki, A; Mishani, E
    Potential F-18-labeled biomarkers for epidermal growth factor receptor tyrosine kinase
    NUCLEAR MEDICINE AND BIOLOGY
    
    T.A. Bonasera et al., "Potential F-18-labeled biomarkers for epidermal growth factor receptor tyrosine kinase", NUCL MED BI, 28(4), 2001, pp. 359-374
49. Garmestani, K; Yao, Z; Zhang, M; Wong, K; Park, CW; Pastan, I; Carrasquillo, JA; Brechbiel, MW
    Synthesis and evaluation of a macrocyclic bifunctional chelating agent foruse with bismuth radionuclides
    NUCLEAR MEDICINE AND BIOLOGY
    
    K. Garmestani et al., "Synthesis and evaluation of a macrocyclic bifunctional chelating agent foruse with bismuth radionuclides", NUCL MED BI, 28(4), 2001, pp. 409-418
50. Henriksen, G; Messelt, S; Olsen, E; Larsen, RH
    Optimisation of cyclotron production parameters for the Bi-209(alpha, 2n) At-211 reaction related to biomedical use of At-211
    APPLIED RADIATION AND ISOTOPES
    
    G. Henriksen et al., "Optimisation of cyclotron production parameters for the Bi-209(alpha, 2n) At-211 reaction related to biomedical use of At-211", APPL RAD IS, 54(5), 2001, pp. 839-844
51. Mavria, G; Porter, CD
    Reduced growth in response to ganciclovir treatment of subcutaneous xenografts expressing HSV-tk in the vascular compartment
    GENE THERAPY
    
    G. Mavria e C.D. Porter, "Reduced growth in response to ganciclovir treatment of subcutaneous xenografts expressing HSV-tk in the vascular compartment", GENE THER, 8(12), 2001, pp. 913-920
52. Tibell, A; Rafael, E; Wennberg, L; Nordenstrom, J; Bergstrom, M; Geller, RL; Loudovaris, T; Johnson, RC; Brauker, JH; Neuenfeldt, S; Wernerson, A
    Survival of macroencapsulated allogeneic parathyroid tissue one year aftertransplantation in nonimmunosuppressed humans
    CELL TRANSPLANTATION
    
    A. Tibell et al., "Survival of macroencapsulated allogeneic parathyroid tissue one year aftertransplantation in nonimmunosuppressed humans", CELL TRANSP, 10(7), 2001, pp. 591-599
53. Tuch, BE; Tabiin, MT; Casamento, FM; Yao, M; Georges, P; Amaratunga, A; Pinto, AN
    Role of pancreatic polypeptide as a market of transplanted insulin-producing fetal pig cells
    CELL TRANSPLANTATION
    
    B.E. Tuch et al., "Role of pancreatic polypeptide as a market of transplanted insulin-producing fetal pig cells", CELL TRANSP, 10(3), 2001, pp. 285-293
54. McKenzie, AW; Georgiou, HM; Zhan, YF; Brady, JL; Lew, AM
    Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody
    CELL TRANSPLANTATION
    
    A.W. McKenzie et al., "Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody", CELL TRANSP, 10(2), 2001, pp. 183-193
55. Brevig, T; Meyer, M; Kristensen, T; Zimmer, J
    Neural xenotransplantation: Pretreatment of porcine embryonic nigral tissue with anti-gal antibodies and complement is not toxic for the dopaminergicneurons
    CELL TRANSPLANTATION
    
    T. Brevig et al., "Neural xenotransplantation: Pretreatment of porcine embryonic nigral tissue with anti-gal antibodies and complement is not toxic for the dopaminergicneurons", CELL TRANSP, 10(1), 2001, pp. 25-30
56. Kiaris, H; Schally, AV; Nagy, A; Szepeshazi, K; Hebert, F; Halmos, G
    A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice
    EUROPEAN JOURNAL OF CANCER
    
    H. Kiaris et al., "A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice", EUR J CANC, 37(5), 2001, pp. 620-628
57. Baselga, J
    Clinical trials of Herceptin (R) (trastuzumab)
    EUROPEAN JOURNAL OF CANCER
    
    J. Baselga, "Clinical trials of Herceptin (R) (trastuzumab)", EUR J CANC, 37, 2001, pp. S18-S24
58. Vogel, C; Cobleigh, MA; Tripathy, D; Gutheil, JC; Harris, LN; Fehrenbacher, L; Slamon, DJ; Murphy, M; Novotny, WF; Burchmore, M; Shak, S; Stewart, SJ
    First-line, single-agent Herceptin (R) (trastuzumab) in metastatic breast cancer: a preliminary report
    EUROPEAN JOURNAL OF CANCER
    
    C. Vogel et al., "First-line, single-agent Herceptin (R) (trastuzumab) in metastatic breast cancer: a preliminary report", EUR J CANC, 37, 2001, pp. S25-S29
59. Johnston, PG; Kaye, S
    Capecitabine: a novel agent for the treatment of solid tumors
    ANTI-CANCER DRUGS
    
    P.G. Johnston e S. Kaye, "Capecitabine: a novel agent for the treatment of solid tumors", ANTI-CANC D, 12(8), 2001, pp. 639-646
60. Sparidans, RW; Rosing, H; Hillebrand, MJX; Lopez-Lazaro, L; Jimeno, JM; Manzanares, I; van Kesteren, C; Cvitkovic, E; van Oosterom, AT; Schellens, JHM; Beijnen, JH
    Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man
    ANTI-CANCER DRUGS
    
    R.W. Sparidans et al., "Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man", ANTI-CANC D, 12(8), 2001, pp. 653-666
61. Stewart, AJ; Mistry, P; Dangerfield, W; Bootle, D; Baker, M; Kofler, B; Okiji, S; Baguley, BC; Denny, WA; Charlton, PA
    Antitumor activity of XR5944, a novel and potent topoisomerase poison
    ANTI-CANCER DRUGS
    
    A.J. Stewart et al., "Antitumor activity of XR5944, a novel and potent topoisomerase poison", ANTI-CANC D, 12(4), 2001, pp. 359-367
62. Huang, PS; Oliff, A
    Drug-targeting strategies in cancer therapy
    CURRENT OPINION IN GENETICS & DEVELOPMENT
    
    P.S. Huang e A. Oliff, "Drug-targeting strategies in cancer therapy", CUR OP GEN, 11(1), 2001, pp. 104-110
63. Zips, D; Eicheler, W; Bruchner, K; Jackisch, T; Geyer, P; Petersen, C; Van der Kogel, AJ; Baumann, M
    Impact of the tumour bed effect on micro environment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    
    D. Zips et al., "Impact of the tumour bed effect on micro environment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse", INT J RAD B, 77(12), 2001, pp. 1185-1193
64. Benda, B; Korsgren, O
    Interleukin-6 in islet xenograft rejection
    TRANSPLANT INTERNATIONAL
    
    B. Benda e O. Korsgren, "Interleukin-6 in islet xenograft rejection", TRANSPLAN I, 14(2), 2001, pp. 63-71
65. Loss, M; Arends, H; Winkler, M; Przemeck, M; Steinhoff, G; Rensing, S; Kaup, FJ; Hedrich, HJ; Winkler, ME; Martin, U
    Analysis of potential porcine endogenous retrovirus (PERV) transmission ina whole-organ xenotransplantation model without interfering microchimerism
    TRANSPLANT INTERNATIONAL
    
    M. Loss et al., "Analysis of potential porcine endogenous retrovirus (PERV) transmission ina whole-organ xenotransplantation model without interfering microchimerism", TRANSPLAN I, 14(1), 2001, pp. 31-37
66. de Groot, FMH; Damen, EWP; Scheeren, HW
    Anticancer prodrugs for application in monotherapy: Targeting hypoxia, tumor-associated enzymes, and receptors
    CURRENT MEDICINAL CHEMISTRY
    
    F.M.H. de Groot et al., "Anticancer prodrugs for application in monotherapy: Targeting hypoxia, tumor-associated enzymes, and receptors", CURR MED CH, 8(9), 2001, pp. 1093-1122
67. Pratesi, G; Monestiroli, SV
    Preclinical evaluation of new anthracyclines
    CURRENT MEDICINAL CHEMISTRY
    
    G. Pratesi e S.V. Monestiroli, "Preclinical evaluation of new anthracyclines", CURR MED CH, 8(1), 2001, pp. 9-13
68. Perego, P; Corna, E; De Cesare, M; Gatti, L; Polizzi, D; Pratesi, G; Supino, R; Zunino, F
    Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines
    CURRENT MEDICINAL CHEMISTRY
    
    P. Perego et al., "Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines", CURR MED CH, 8(1), 2001, pp. 31-37
69. Christodoulou, C; Bafaloukos, D; Kosmidis, P; Samantas, E; Bamias, A; Papakostas, P; Karabelis, A; Bacoyiannis, C; Skarlos, DV
    Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
    ANNALS OF ONCOLOGY
    
    C. Christodoulou et al., "Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases", ANN ONCOL, 12(2), 2001, pp. 249-254
70. Kinuya, S; Yokoyama, K; Kobayashi, K; Motoishi, S; Onoma, K; Watanabe, N; Shuke, N; Bunko, H; Michigishi, T; Tonami, N
    Experimental radioimmunotherapy with Re-186-MAG3-A7 anti-colorectal cancermonoclonal antibody: Comparison with I-131-counterpart
    ANNALS OF NUCLEAR MEDICINE
    
    S. Kinuya et al., "Experimental radioimmunotherapy with Re-186-MAG3-A7 anti-colorectal cancermonoclonal antibody: Comparison with I-131-counterpart", ANN NUCL M, 15(3), 2001, pp. 199-202
71. Ohta, M; Konno, H; Tanaka, T; Baba, M; Kamiya, K; Oba, K; Kaneko, T; Syouji, T; Igarashi, A; Nakamura, S
    Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    M. Ohta et al., "Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer", JPN J CANC, 92(6), 2001, pp. 688-695
72. Abe, S; Kubota, T; Otani, Y; Furukawa, T; Watanabe, M; Kumai, K; Akiyama, T; Akinaga, S; Kitajima, M
    UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    S. Abe et al., "UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery", JPN J CANC, 92(5), 2001, pp. 537-545
73. Shimamoto, Y; Fujioka, A; Kazuno, H; Murakami, Y; Ohshimo, H; Kato, T; Matsuda, A; Sasaki, T; Fukushima, M
    Antitumor activity and pharmacokinetics of TAS-106, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    Y. Shimamoto et al., "Antitumor activity and pharmacokinetics of TAS-106, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine", JPN J CANC, 92(3), 2001, pp. 343-351
74. Vriens, PW; Stoot, JH; Hoyt, G; Scheringa, M; Bouwman, E; Robbins, RC
    Pre-transplant blood transfusion induces tolerance to hamster cardiac xenografts in athymic nude rats
    XENOTRANSPLANTATION
    
    P.W. Vriens et al., "Pre-transplant blood transfusion induces tolerance to hamster cardiac xenografts in athymic nude rats", XENOTRANSPL, 8(4), 2001, pp. 247-257
75. Chen, DX; Riesbeck, K; McVey, JH; Kemball-Cook, G; Tuddenham, EGD; Lechler, RI; Dorling, A
    Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins
    XENOTRANSPLANTATION
    
    D.X. Chen et al., "Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins", XENOTRANSPL, 8(4), 2001, pp. 258-265
76. Wu, GD; Gochi, E; Jin, YS; Swensson, J; Starnes, VA; Cramer, DV
    Maturation of xenoantibody gene expression during the humoral immune response of rats to hamster xenografts
    XENOTRANSPLANTATION
    
    G.D. Wu et al., "Maturation of xenoantibody gene expression during the humoral immune response of rats to hamster xenografts", XENOTRANSPL, 8(4), 2001, pp. 291-302
77. Stephan, O; Schwendemann, J; Specke, V; Tacke, SJ; Boller, K; Denner, J
    Porcine endogenous retroviruses (PERVs): Generation of specific antibodies, development of an immunoperoxidase assay (IPA) and inhibition by AZT
    XENOTRANSPLANTATION
    
    O. Stephan et al., "Porcine endogenous retroviruses (PERVs): Generation of specific antibodies, development of an immunoperoxidase assay (IPA) and inhibition by AZT", XENOTRANSPL, 8(4), 2001, pp. 310-316
78. Tacke, SJ; Bodusch, K; Berg, A; Denner, J
    Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation
    XENOTRANSPLANTATION
    
    S.J. Tacke et al., "Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation", XENOTRANSPL, 8(2), 2001, pp. 125-135
79. Remy, S; Canova, C; Daguin-Nerriere, V; Martin, C; Melchior, B; Neveu, I; Charreau, B; Soulillou, JP; Brachet, P
    Different mechanisms mediate the rejection of porcine neurons and endothelial cells transplanted into the rat brain
    XENOTRANSPLANTATION
    
    S. Remy et al., "Different mechanisms mediate the rejection of porcine neurons and endothelial cells transplanted into the rat brain", XENOTRANSPL, 8(2), 2001, pp. 136-148
80. Fiorante, P; Banz, Y; Mohacsi, PJ; Kappeler, A; Wuillemin, WA; Macchiarini, P; Roos, A; Daha, MR; Schaffner, T; Haeberli, A; Mazmanian, GM; Rieben, R
    Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models
    XENOTRANSPLANTATION
    
    P. Fiorante et al., "Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models", XENOTRANSPL, 8(1), 2001, pp. 24-35
81. Loss, M; Schmidtko, J; Przemeck, M; Kunz, R; Arends, H; Jalali, A; Lorenz, R; Piepenbrock, S; Klempnauer, J; Winkler, M
    A primate model for discordant pig to primate kidney xenotransplantation without hyperacute graft rejection
    JOURNAL OF INVESTIGATIVE SURGERY
    
    M. Loss et al., "A primate model for discordant pig to primate kidney xenotransplantation without hyperacute graft rejection", J INVES SUR, 14(1), 2001, pp. 21-29
82. Pettersson, F; Colston, KW; Dalgleish, AG
    Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells
    PANCREAS
    
    F. Pettersson et al., "Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells", PANCREAS, 23(3), 2001, pp. 273-279
83. Taamma, A; Misset, JL; Riofrio, M; Guzman, C; Brain, E; Lazaro, LL; Rosing, H; Jimeno, JM; Cvitkovic, E
    Phase I and pharmacokinetic study of ecteinaseidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors
    JOURNAL OF CLINICAL ONCOLOGY
    
    A. Taamma et al., "Phase I and pharmacokinetic study of ecteinaseidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors", J CL ONCOL, 19(5), 2001, pp. 1256-1265
84. Fisher, BJ; Scott, C; Macdonald, DR; Coughlin, C; Curran, WJ
    Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507
    JOURNAL OF CLINICAL ONCOLOGY
    
    B.J. Fisher et al., "Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507", J CL ONCOL, 19(4), 2001, pp. 1111-1117
85. Saylors, RL; Stine, KC; Sullivan, J; Kepner, JL; Wall, DA; Bernstein, ML; Harris, MB; Hayashi, R; Vietti, TJ
    Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: A pediatric oncology group phase II study
    JOURNAL OF CLINICAL ONCOLOGY
    
    R.L. Saylors et al., "Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: A pediatric oncology group phase II study", J CL ONCOL, 19(15), 2001, pp. 3463-3469
86. Hawkins, DS; Anderson, JR; Paidas, CN; Wharam, MD; Qualman, SJ; Pappo, AS; Baker, KS; Crist, WM
    Improved outcome for patients with middle ear rhabdomyosarcoma: A children's oncology group study
    JOURNAL OF CLINICAL ONCOLOGY
    
    D.S. Hawkins et al., "Improved outcome for patients with middle ear rhabdomyosarcoma: A children's oncology group study", J CL ONCOL, 19(12), 2001, pp. 3073-3079
87. Sparano, JA; Malik, U; Rajdev, L; Sarta, C; Hopkins, U; Wolff, AC
    Phase I trial of pegylated liposomal doxorubicin and docetaxel in advancedbreast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    J.A. Sparano et al., "Phase I trial of pegylated liposomal doxorubicin and docetaxel in advancedbreast cancer", J CL ONCOL, 19(12), 2001, pp. 3117-3125
88. Pappo, AS; Lyden, E; Breneman, J; Wiener, E; Teot, L; Meza, J; Crist, W; Vietti, T
    Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study
    JOURNAL OF CLINICAL ONCOLOGY
    
    A.S. Pappo et al., "Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study", J CL ONCOL, 19(1), 2001, pp. 213-219
89. Del Bufalo, D; Trisciuoglio, D; Biroccio, A; Marcocci, L; Buglioni, S; Candiloro, A; Scarsella, M; Leonetti, C; Zupi, G
    Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    D. Del Bufalo et al., "Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity", J CELL BIOC, 83(3), 2001, pp. 473-483
90. Shah, SA; Potter, MW; McDade, TP; Ricciardi, R; Perugini, RA; Elliott, PJ; Adams, J; Callery, MP
    26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    S.A. Shah et al., "26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer", J CELL BIOC, 82(1), 2001, pp. 110-122
91. Tsukamoto, Y; Kato, Y; Ura, M; Horii, I; Ishitsuka, H; Kusuhara, H; Sugiyama, Y
    A physiologically based pharmacokinetic analysis of capecitabine, a tripleprodrug of 5-FU, in humans: The mechanism for tumor-selective accumulationof 5-FU
    PHARMACEUTICAL RESEARCH
    
    Y. Tsukamoto et al., "A physiologically based pharmacokinetic analysis of capecitabine, a tripleprodrug of 5-FU, in humans: The mechanism for tumor-selective accumulationof 5-FU", PHARM RES, 18(8), 2001, pp. 1190-1202
92. Domenick, MA; Ildstad, ST
    Impact of bone marrow transplantation on type I diabetes
    WORLD JOURNAL OF SURGERY
    
    M.A. Domenick e S.T. Ildstad, "Impact of bone marrow transplantation on type I diabetes", WORLD J SUR, 25(4), 2001, pp. 474-480
93. Chauhan, NB; Siegel, GJ; Lichtor, T
    Distribution of intraventricularly administered antiamyloid-beta peptide (A beta) antibody in the mouse brain
    JOURNAL OF NEUROSCIENCE RESEARCH
    
    N.B. Chauhan et al., "Distribution of intraventricularly administered antiamyloid-beta peptide (A beta) antibody in the mouse brain", J NEUROSC R, 66(2), 2001, pp. 231-235
94. Wijffels, KIEM; Kaanders, JHAM; Marres, HAM; Bussink, J; Peters, HPW; Rijken, PFJW; van den Hoogen, FJA; de Wilde, PCM; van der Kogel, AJ
    Patterns of proliferation related to vasculature in human head-and-neck carcinomas before and after transplantation in nude mice
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    K.I.E.M. Wijffels et al., "Patterns of proliferation related to vasculature in human head-and-neck carcinomas before and after transplantation in nude mice", INT J RAD O, 51(5), 2001, pp. 1346-1353
95. Petersen, C; Zips, D; Krause, M; Schone, K; Eicheler, W; Hoinkis, C; Thames, HD; Baumann, M
    Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    C. Petersen et al., "Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation", INT J RAD O, 51(2), 2001, pp. 483-493
96. Chastagner, P; Kozin, SV; Taghian, A
    Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    P. Chastagner et al., "Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice", INT J RAD O, 50(3), 2001, pp. 777-782
97. Feyerabend, T; Wiedemann, GJ; Jager, B; Vesely, H; Mahlmann, B; Richter, E
    Local hyperthermia, radiation, and chemotherapy in recurrent breast canceris feasible and effective except for inflammatory disease
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    T. Feyerabend et al., "Local hyperthermia, radiation, and chemotherapy in recurrent breast canceris feasible and effective except for inflammatory disease", INT J RAD O, 49(5), 2001, pp. 1317-1325
98. Hunjan, S; Zhao, DW; Constantinescu, A; Hahn, EW; Antich, PP; Mason, RP
    Tumor oximetry: Demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    S. Hunjan et al., "Tumor oximetry: Demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor", INT J RAD O, 49(4), 2001, pp. 1097-1108
99. Ressel, A; Weiss, C; Feyerabend, T
    Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    A. Ressel et al., "Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival", INT J RAD O, 49(4), 2001, pp. 1119-1125
100. Areberg, J; Wennerberg, J; Johnsson, A; Norrgren, K; Mattsson, S
     Antitumor effect of radioactive cisplatin (Pt-191) on nude mice
     INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
     
     J. Areberg et al., "Antitumor effect of radioactive cisplatin (Pt-191) on nude mice", INT J RAD O, 49(3), 2001, pp. 827-832